Asuragen Incorporated
UnclaimedIn-Vitro Diagnostic Substance ManufacturingAustin, TX
Founded
2006
Primary NAICS
325413
CAGE code
4GGP6
Federal awards
$627.6K
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vitro (i.e., not taken internally) diagnostic substances, such as chemical, biological, or radioactive substances. The substances are used for diagnostic tests that are performed in test tubes, petri dishes, machines, and other diagnostic test-type devices.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- In-Vitro Diagnostic Substance Manufacturing325413
Capabilities
Biological Product (except Diagnostic) ManufacturingResearch and Development in Biotechnology (except Nanobiotechnology)Medical LaboratoriesIn Vitro Diagnostic Substances, Reagents, Test Kits and SetsHealth R&D Services; Health Care Services; Experimental DevelopmentQuality Control- Medical, Dental, and Veterinary Equipment and Supplies
Federal awards
| Year | Agency | Obligated | Actions |
|---|---|---|---|
| 2026 | Department of Defense | $77,360 | 3 |
| 2025 | Department of Defense | $169,115 | 3 |
| 2024 | Department of Defense | $180,888 | 2 |
| 2023 | Department of Defense | $125,130 | 4 |
| 2023 | Department of Health and Human Services | $75,075 | 1 |
| 2022 | Department of Defense | $0 | 3 |